フローサイトメトリー市場：技術（セルベース、ビーズベース）、製品・サービス（アナライザー、ソーター、消耗品、ソフトウェア）、アプリケーション（（研究-免疫学、幹細胞）、（臨床-血液学））、エンドユーザー（バイオテクノロジー、病院）-2027年までの世界市場予測

Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application ((Research - Immunology, Stem cell), (Clinical - Hematology)), End user (Biotech, Hospitals) - Global Forecast to 2027

フローサイトメトリーの世界市場は、2022年の47億ドルから2027年には69億ドルに達すると予測され、予測期間中のCAGRは8.1%である。HIV/AIDS、癌、自己免疫疾患の世界的な流行が、診断のためのフローサイトメトリ... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2022年8月29日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	319	369	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

フローサイトメトリーの世界市場は、2022年の47億ドルから2027年には69億ドルに達すると予測され、予測期間中のCAGRは8.1%である。HIV/AIDS、癌、自己免疫疾患の世界的な流行が、診断のためのフローサイトメトリーの採用を増加させ、市場成長を予測しています。さらに、技術的に進化した製品の発売が、2022-2027年の予測期間中に市場成長を促進する可能性があります。

"2021年のフローサイトメトリー世界市場では、インストルメント部門がかなりのシェアを占めました。"

製品・サービスに基づいて、市場は試薬・消耗品、機器、サービス、ソフトウェア、アクセサリーに区分されます。試薬＆消耗品セグメントは2021年の市場で圧倒的なシェアを占め、予測期間中も優位性を保つと予測されます。研究をより速いペースで成長させる新しい試薬＆消耗品の市場投入は、セグメント成長を促進すると思われる。2021年11月、Bio-Rad Laboratories, Inc.（米国）は、フローサイトメトリーアプリケーションでUVレーザーを使用するために設計された蛍光ナノ粒子「StarBright UltraViolet 400 Dye」を発売しました。

"2021年、研究用途セグメントが市場を独占"

エンドユーザーに基づいて、フローサイトメトリー市場は、研究アプリケーション、臨床アプリケーション、産業アプリケーションに区分されます。フローサイトメトリーの臨床アプリケーションにおける主要な市場プレイヤーの強い注力は、セグメントの成長を予測するものと思われます。2021年10月、BD（Becton, Dickinson and Company）（米国）は、Christian Medical College Vellore（インド）と共同で、インドにおける臨床研究のためのフローサイトメトリーにおける2番目のCoE（Center of Excellence）を立ち上げた。

"2021年、北米が圧倒的なシェアを占める"
フローサイトメトリー市場は、地域的には、北米、欧州、アジア太平洋、中南米、中東・アフリカに区分されます。2021年のフローサイトメトリー市場は、北米が主要シェアを占めています。北米は、主要な市場プレイヤーの存在と、同地域における研究アプリケーションでのフローサイトメトリー採用の増加により、支配的なシェアを占めた。アジア太平洋地域は、研究資金の増加や臨床アプリケーションでのフローサイトメトリーの採用により、より速いペースで成長すると予想される。

本レポートのために実施した一次インタビューは、以下のように分類される。
- 企業タイプ別 - サプライサイド: 70.0%, デマンドサイド: 30.0
- 役職別 - マネージャー: 45.0%, CXO & ディレクター: 30.0%, 経営幹部: 25.0
- 地域別：北米20％、欧州10％、アジア太平洋55％、中南米10％、中東・アフリカ5
報告書に掲載された企業一覧
o ベクトン・ディッキンソン・アンド・カンパニー（米国）
o ダナハーコーポレーション（米国）
o サーモフィッシャーサイエンティフィック（米国）
ルミネックスコーポレーション（米国）
o アジレント・テクノロジー株式会社（米国）
ソニーグループ (日本)
バイオ・ラッド・ラボラトリーズ（米国）
ミルテニ・バイオテック社（ドイツ）
エンゾ・バイオケム社（米国）
シスメックス株式会社（日本）
bioMérieux S.A.(フランス)
o Cytonome/ST、LLC（米国）
o サルトリウスAG（ドイツ）
o サイテック・バイオサイエンシズ株式会社（米国）
ユニオン・バイオメトリカ（米国）
アポジーフローシステムズ社（英国(英国)
o Stratedigm, Inc.（米国）
ナノセレクトバイオメディカル（米国）
o オンチップ・バイオテクノロジーズ（株(日本)
o BennuBio Inc.(米国)
o ORFLO Technologies（米国）
o Bay Biosciences Co.(日本)
o BioLegend, Inc.（米国）
o CytoBuoy B.V (オランダ).
調査対象範囲
本レポートは、世界のフローサイトメトリー市場の詳細な情報を提供します。技術、製品・サービス、アプリケーション、エンドユーザー、地域など、さまざまなセグメントにおける市場規模と今後の成長性を推定することを目的としています。また、市場成長に影響を与える要因（ドライバー、阻害要因、機会など）を分析しています。利害関係者向けに市場の機会を評価し、市場リーダー向けに競争環境の詳細を提供しています。また、マイクロマーケットについて、その成長動向、展望、フローサイトメトリー市場全体への貢献度に関しても調査しています。本レポートでは、4つの主要地域に関して、市場セグメントの収益を予測しています。

レポートを購入する理由
本レポートは、以下のポイントに関する洞察を提供しています。
- 市場の浸透。フローサイトメトリー市場の上位25社が提供する細胞分析に関する包括的な情報。フローサイトメトリー市場を技術、製品＆サービス、アプリケーション、エンドユーザー、地域別に分析しています。

- 市場開発。有利な新興市場に関する包括的な情報です。本レポートでは、主要な地域ごとの各種フローサイトメトリー製品の市場について分析しています。

- 市場の多様化。フローサイトメトリー市場における新製品、未開拓の地域、最近の開発、投資に関する情報を網羅的に提供します。

- 競争力の評価。フローサイトメトリー市場における主要企業の市場ランキングと戦略に関する詳細な評価。

ページTOPに戻る

1 INTRODUCTION 43
1.1 STUDY OBJECTIVES 43
1.2 MARKET DEFINITION 43
1.2.1 INCLUSIONS & EXCLUSIONS 44
1.3 STUDY SCOPE 44
1.3.1 MARKETS COVERED 44
1.3.2 YEARS CONSIDERED 45
1.4 CURRENCY CONSIDERED 45
1.5 LIMITATIONS 45
1.6 STAKEHOLDERS 46
1.7 SUMMARY OF CHANGES 46
2 RESEARCH METHODOLOGY 48
2.1 RESEARCH DATA 48
FIGURE 1 RESEARCH DESIGN 48
2.1.1 SECONDARY DATA 49
2.1.2 PRIMARY DATA 50
FIGURE 2 FLOW CYTOMETRY MARKET: BREAKDOWN OF PRIMARIES 50
2.2 MARKET ESTIMATION METHODOLOGY 51
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 51
FIGURE 3 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 52
FIGURE 4 AVERAGE MARKET SIZE ESTIMATION (2021) 52
2.3 DATA TRIANGULATION APPROACH 54
FIGURE 5 DATA TRIANGULATION METHODOLOGY 54
2.4 GROWTH FORECAST 55
2.5 LIMITATIONS 55
2.6 RISK ASSESSMENT 55
2.7 CAGR PROJECTIONS 56
2.7.1 SUPPLY-SIDE ANALYSIS 56
2.7.2 DEMAND-SIDE ANALYSIS 56
2.7.3 INSIGHTS FROM PRIMARY EXPERTS 57
3 EXECUTIVE SUMMARY 58
FIGURE 6 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION) 58
FIGURE 7 FLOW CYTOMETRY MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 59
FIGURE 8 FLOW CYTOMETRY MARKET, BY END USER, 2021 59
FIGURE 9 GEOGRAPHICAL SNAPSHOT 60
4 PREMIUM INSIGHTS 61
4.1 FLOW CYTOMETRY MARKET OVERVIEW 61
FIGURE 10 INCREASING PREVALENCE OF AUTOIMMUNE DISEASES AND RISING ADVANCEMENTS IN FLOW CYTOMETRY TECHNIQUES DRIVE MARKET GROWTH 61
4.2 ASIA PACIFIC: FLOW CYTOMETRY MARKET SHARE, BY PRODUCT & SERVICE (2021) 62
FIGURE 11 REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2021 62
4.3 FLOW CYTOMETRY MARKET SHARE, BY TECHNOLOGY, 2022 VS. 2027 63
FIGURE 12 CELL-BASED FLOW CYTOMETRY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 63
4.4 FLOW CYTOMETRY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 64
FIGURE 13 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 64
5 MARKET OVERVIEW 65
5.1 INTRODUCTION 65
5.2 MARKET DYNAMICS 65
FIGURE 14 FLOW CYTOMETRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 65
5.2.1 DRIVERS 66
5.2.1.1 Increasing incidence of HIV/AIDS and cancer 66
TABLE 1 INCIDENCE OF HIV/AIDS, BY REGION, 2020 66
TABLE 2 CANCER INCIDENCE, 2020 VS. 2040 66
5.2.1.2 Flow cytometry techniques in research activities 67
5.2.1.3 Use of flow cytometry in regenerative medicine 68
5.2.1.4 Growing public−private initiatives in immunology and immuno-oncology research 68
5.2.1.5 Technological advancements in flow cytometry instruments 69
TABLE 3 IMPORTANT TECHNOLOGICAL ADVANCEMENTS (2019–2022) 69
5.2.2 RESTRAINTS 70
5.2.2.1 High product cost 70
5.2.3 OPPORTUNITIES 71
5.2.3.1 Emerging markets 71
5.2.3.2 Public-private funding initiatives in stem cell research 71
TABLE 4 NIH-ESTIMATED STEM CELL RESEARCH EXPENDITURE DATA 72
5.2.3.3 Adoption of recombinant DNA technology for antibody production 72
5.2.4 CHALLENGES 72
5.2.4.1 Complexities related to reagent development 72
5.2.4.2 Shortage of well-trained and skilled professionals 73
5.3 PATENT ANALYSIS 73
5.3.1 LIST OF MAJOR PATENTS 74
5.4 SUPPLY CHAIN ANALYSIS 76
FIGURE 15 DIRECT DISTRIBUTION STRATEGY PREFERRED BY PROMINENT COMPANIES 77
5.4.1 KEY INFLUENCERS 77
5.5 VALUE CHAIN ANALYSIS 78
FIGURE 16 FLOW CYTOMETRY MARKET: VALUE CHAIN ANALYSIS 78
5.6 ECOSYSTEM ANALYSIS 79
FIGURE 17 FLOW CYTOMETRY MARKET: ECOSYSTEM ANALYSIS 79
5.6.1 ROLE IN ECOSYSTEM 79
5.7 REGULATORY ASSESSMENT 80
5.7.1 STRINGENT FDA REQUIREMENTS 80
5.7.2 ANALYTE-SPECIFIC REAGENT RULE 80
5.7.3 LIMITATIONS IN VALIDATION PROTOCOLS FOR CELL-BASED ASSAYS 80
5.7.4 ABSENCE OF TEST GUIDELINES ON CELL-BASED FLUORESCENCE ASSAYS 80
5.7.5 IVD CE MARK APPROVALS 81
5.7.6 US: REIMBURSEMENT SCENARIO 81
5.8 PORTER’S FIVE FORCES ANALYSIS 82
TABLE 5 FLOW CYTOMETRY MARKET- PORTER’S FIVE FORCES ANALYSIS 82
5.8.1 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS 82
5.8.2 BARGAINING POWER OF SUPPLIERS 82
5.8.3 BARGAINING POWER OF BUYERS 83
5.8.4 THREAT OF SUBSTITUTES 83
5.8.5 THREAT OF NEW ENTRANTS 83
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 84
FIGURE 18 REVENUE SHIFT & NEW REVENUE POCKETS FOR FLOW CYTOMETRY MARKET 84
5.10 KEY CONFERENCES & EVENTS IN 2022-2023 84
TABLE 6 FLOW CYTOMETRY MARKET: DETAILED LIST OF EVENTS AND CONFERENCES 84
5.11 TRADE DATA 85
TABLE 7 IMPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2017–2021 (USD THOUSAND) 85
TABLE 8 IMPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2017–2021 (USD THOUSAND) 86
5.12 PRICING ANALYSIS 87
TABLE 9 COST OF FLOW CYTOMETERS, BY TYPE 87
TABLE 10 COST OF FLOW CYTOMETERS & OTHER PRODUCTS, BY COMPANY 87
5.12.1 COST OF FLOW CYTOMETRY SOFTWARE 87
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 88
FIGURE 19 KEY STAKEHOLDERS IN PHARMACEUTICAL COMPANIES AND INFLUENCES ON BUYING PROCESSES 88
FIGURE 20 KEY BUYING CRITERIA FOR FLOW CYTOMETRY PRODUCTS AMONG END USERS 88
6 FLOW CYTOMETRY MARKET, BY TECHNOLOGY 89
6.1 INTRODUCTION 90
TABLE 11 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 90

6.2 CELL-BASED FLOW CYTOMETRY 90
6.2.1 RISING R&D INVESTMENTS FOR NEW THERAPEUTIC AGENTS TO DRIVE MARKET GROWTH 90
TABLE 12 CELL-BASED FLOW CYTOMETRY MARKET, BY REGION, 2020–2027 (USD MILLION) 91
6.3 BEAD-BASED FLOW CYTOMETRY 91
6.3.1 HIGH RELIABILITY AND MEASUREMENT CONSISTENCIES OF BEAD-BASED FLOW CYTOMETRY TO SUPPORT GROWTH 91
TABLE 13 BEAD-BASED FLOW CYTOMETRY MARKET, BY REGION, 2020–2027 (USD MILLION) 92
7 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE 93
7.1 INTRODUCTION 94
TABLE 14 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 94
7.2 REAGENTS & CONSUMABLES 94
7.2.1 INCREASING INVESTMENTS IN RESEARCH TO DRIVE MARKET DEMAND 94
TABLE 15 FLOW CYTOMETRY REAGENTS & CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION) 95
7.3 INSTRUMENTS 95
7.3.1 LAUNCH OF TECHNOLOGICALLY ADVANCED INSTRUMENTS TO PROPEL MARKET GROWTH 95
TABLE 16 FLOW CYTOMETRY INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION) 96
TABLE 17 FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 96
7.3.2 CELL ANALYZERS 96
7.3.2.1 Investments by leading market players in developing cell analyzers to drive market growth 96
TABLE 18 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY REGION, 2020–2027 (USD MILLION) 97
TABLE 19 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY PRICE RANGE, 2020–2027 (USD MILLION) 97
7.3.2.2 High-range cell analyzers 98
7.3.2.2.1 Wide adoption of high-range cell analyzers among end users to drive market growth 98
TABLE 20 HIGH-RANGE CELL ANALYZERS MARKET, BY REGION, 2020–2027 (USD MILLION) 98
7.3.2.3 Mid-range cell analyzers 98
7.3.2.3.1 Availability of compact & high-performance analyzers to support market growth 98
TABLE 21 MID-RANGE CELL ANALYZERS MARKET, BY REGION, 2020–2027 (USD MILLION) 99
7.3.2.4 Low-range cell analyzers 99
7.3.2.4.1 Low-range analyzers significantly adopted among price-sensitive end users 99
TABLE 22 LOW-RANGE CELL ANALYZERS MARKET, BY REGION, 2020–2027 (USD MILLION) 99
7.3.3 CELL SORTERS 100
TABLE 23 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY REGION, 2020–2027 (USD MILLION) 100
TABLE 24 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY PRICE RANGE, 2020–2027 (USD MILLION) 101
7.3.3.1 High-range cell sorters 101
7.3.3.1.1 High cost and budgetary limitations to restrain market growth 101
TABLE 25 HIGH-RANGE CELL SORTERS MARKET, BY REGION, 2020–2027 (USD MILLION) 101
7.3.3.2 Mid-range cell sorters 102
7.3.3.2.1 Cost-efficiency & frequent product launches for mid-range sorters to drive market growth 102
TABLE 26 MID-RANGE CELL SORTERS MARKET, BY REGION, 2020–2027 (USD MILLION) 102
7.3.3.3 Low-range cell sorters 102
7.3.3.3.1 Small-scale labs and research facilities to be major end users of low-range sorters 102
TABLE 27 LOW-RANGE CELL SORTERS MARKET, BY REGION, 2020–2027 (USD MILLION) 103
7.4 SERVICES 103
7.4.1 FLOW CYTOMETRY SERVICES TO ENSURE WORKFLOW CONTINUITY AND MAXIMIZE PERFORMANCE 103
TABLE 28 FLOW CYTOMETRY SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 103
7.5 SOFTWARE 104
7.5.1 TECHNOLOGICAL ADVANCEMENTS IN SOFTWARE TO DRIVE MARKET GROWTH 104
TABLE 29 FLOW CYTOMETRY SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION) 104
7.6 ACCESSORIES 105
7.6.1 PROCEDURAL BENEFITS OFFERED BY FLOW CYTOMETRY ACCESSORIES TO SUPPORT MARKET GROWTH 105
TABLE 30 FLOW CYTOMETRY ACCESSORIES MARKET, BY REGION, 2020–2027 (USD MILLION) 105
8 FLOW CYTOMETRY MARKET, BY APPLICATION 106
8.1 INTRODUCTION 107
TABLE 31 FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 107
8.2 RESEARCH APPLICATIONS 107
TABLE 32 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 108
TABLE 33 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 108

8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY 108
TABLE 34 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY,
BY TYPE, 2020–2027 (USD MILLION) 109
8.2.1.1 Drug discovery 109
8.2.1.1.1 Growing use of phenotypic cell-based assays in drug discovery to support market growth 109
TABLE 35 FLOW CYTOMETRY MARKET FOR DRUG DISCOVERY, BY REGION, 2020–2027 (USD MILLION) 110
8.2.1.2 Stem cell research 110
8.2.1.2.1 Increasing investments in stem cell research to drive demand for flow cytometry products 110
TABLE 36 FLOW CYTOMETRY MARKET FOR STEM CELL RESEARCH, BY REGION, 2020–2027 (USD MILLION) 111
8.2.1.3 In vitro toxicity testing 111
8.2.1.3.1 Growing adoption of flow cytometry in drug discovery & development to support market growth 111
TABLE 37 FLOW CYTOMETRY MARKET FOR IN VITRO TOXICITY TESTING, BY REGION, 2020–2027 (USD MILLION) 112
8.2.2 IMMUNOLOGY 112
8.2.2.1 Growing prevalence of infectious & autoimmune diseases to support market growth 112
TABLE 38 FLOW CYTOMETRY MARKET FOR IMMUNOLOGY, BY REGION, 2020–2027 (USD MILLION) 113
8.2.3 CELL SORTING 113
8.2.3.1 Technologically advanced cell sorters to drive market growth 113
TABLE 39 FLOW CYTOMETRY MARKET FOR CELL SORTING, BY REGION, 2020–2027 (USD MILLION) 114
8.2.4 APOPTOSIS 114
8.2.4.1 Growing use of apoptosis assays to support market growth 114
TABLE 40 FLOW CYTOMETRY MARKET FOR APOPTOSIS, BY REGION, 2020–2027 (USD MILLION) 114
8.2.5 CELL CYCLE ANALYSIS 115
8.2.5.1 Use of flowcytometry to detect chromosomal abnormalities 115
TABLE 41 FLOW CYTOMETRY MARKET FOR CELL CYCLE ANALYSIS, BY REGION, 2020–2027 (USD MILLION) 115
8.2.6 CELL VIABILITY 115
8.2.6.1 Growing use of cell viability assays in research to support market growth 115
TABLE 42 FLOW CYTOMETRY MARKET FOR CELL VIABILITY, BY REGION, 2020–2027 (USD MILLION) 116
8.2.7 CELL COUNTING 116
8.2.7.1 Flow cytometry permits easy differentiation of cells via scattering or staining 116
TABLE 43 FLOW CYTOMETRY MARKET FOR CELL COUNTING, BY REGION, 2020–2027 (USD MILLION) 117

8.2.8 OTHER RESEARCH APPLICATIONS 117
TABLE 44 FLOW CYTOMETRY MARKET FOR OTHER RESEARCH APPLICATIONS,
BY REGION, 2020–2027 (USD MILLION) 117
8.3 CLINICAL APPLICATIONS 118
TABLE 45 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 46 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 118
8.3.1 CANCER 119
8.3.1.1 Growing use of flow cytometry techniques in cancer predictions to drive market growth 119
TABLE 47 ESTIMATED NUMBER OF NEW CANCER CASES (2020–2040) 119
TABLE 48 FLOW CYTOMETRY MARKET FOR CANCER, BY REGION, 2020–2027 (USD MILLION) 120
8.3.2 HEMATOLOGY 120
8.3.2.1 Increasing use of flow cytometry in hematology applications to drive market growth 120
TABLE 49 FLOW CYTOMETRY MARKET FOR HEMATOLOGY, BY REGION, 2020–2027 (USD MILLION) 120
8.4 IMMUNODEFICIENCY DISEASES 121
8.4.1 BENEFITS OF FLOW CYTOMETRY IN DIAGNOSIS OF IMMUNODEFICIENCY DISEASES TO DRIVE MARKET GROWTH 121
TABLE 50 APPLICATION OF FLOW CYTOMETRY IN DIAGNOSIS OF PRIMARY IMMUNODEFICIENCY DISEASES. 121
TABLE 51 FLOW CYTOMETRY MARKET FOR IMMUNODEFICIENCY DISEASE, BY REGION, 2020–2027 (USD MILLION) 123
8.4.2 ORGAN & TISSUE TRANSPLANTATION 123
8.4.2.1 Increasing organ transplants worldwide to drive market growth 123
TABLE 52 FLOW CYTOMETRY MARKET FOR ORGAN TRANSPLANTATION, BY REGION, 2020–2027 (USD MILLION) 124
8.4.3 OTHER CLINICAL APPLICATIONS 124
TABLE 53 FLOW CYTOMETRY MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 124
8.5 INDUSTRIAL APPLICATIONS 125
8.5.1 GROWING USE OF FLOW CYTOMETRY TECHNIQUES IN FOOD & DIARY TO SUPPORT MARKET GROWTH 125
TABLE 54 FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 125
9 FLOW CYTOMETRY MARKET, BY END USER 126
9.1 INTRODUCTION 127
TABLE 55 FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 127
9.2 ACADEMIC & RESEARCH INSTITUTES 127
9.2.1 GROWING COLLABORATIONS AMONG ACADEMIC & RESEARCH INSTITUTES EXPECTED TO DRIVE MARKET 127
TABLE 56 FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION) 128
9.3 HOSPITALS & CLINICAL TESTING LABORATORIES 129
9.3.1 USE OF FLOW CYTOMETRY TECHNIQUES IN INFECTIOUS DISEASE DIAGNOSTICS TO DRIVE MARKET GROWTH 129
TABLE 57 FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2020–2027 (USD MILLION) 129
9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 130
9.4.1 INCREASING INVESTMENTS IN DRUG DISCOVERY & DEVELOPMENT TO SUPPORT MARKET GROWTH 130
TABLE 58 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION) 130
10 FLOW CYTOMETRY MARKET, BY REGION 131
10.1 INTRODUCTION 132
TABLE 59 FLOW CYTOMETRY MARKET, BY REGION, 2020–2027 (USD MILLION) 132
10.2 NORTH AMERICA 132
FIGURE 21 NORTH AMERICA: FLOW CYTOMETRY MARKET SNAPSHOT 133
TABLE 60 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 133
TABLE 61 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 134
TABLE 62 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 134
TABLE 63 NORTH AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 64 NORTH AMERICA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 65 NORTH AMERICA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 66 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 135
TABLE 67 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 136
TABLE 68 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 136
TABLE 69 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 137
TABLE 70 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 137
10.2.1 US 138
10.2.1.1 High incidence of cancer and HIV-AIDS to drive market growth 138
TABLE 71 US: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 139
TABLE 72 US: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 139
TABLE 73 US: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 74 US: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 75 US: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 76 US: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 140
TABLE 77 US: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 141
TABLE 78 US: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 141
TABLE 79 US: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 142
TABLE 80 US: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 142
10.2.2 CANADA 143
10.2.2.1 Ongoing government initiatives for life science research to drive demand 143
TABLE 81 CANADA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 144
TABLE 82 CANADA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 144
TABLE 83 CANADA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 84 CANADA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 145
TABLE 85 CANADA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 145
TABLE 86 CANADA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 87 CANADA: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 146
TABLE 88 CANADA: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 146
TABLE 89 CANADA: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 147
TABLE 90 CANADA: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 147
10.3 EUROPE 147
TABLE 91 EUROPE: FLOW CYTOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 148
TABLE 92 EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 148
TABLE 93 EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 149
TABLE 94 EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 95 EUROPE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 96 EUROPE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 97 EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 98 EUROPE: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 151
TABLE 99 EUROPE: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 151
TABLE 100 EUROPE: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 152
TABLE 101 EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 152
10.3.1 GERMANY 153
10.3.1.1 Strong research & development infrastructure and awareness programs on flow cytometry to ensure market growth 153
TABLE 102 GERMANY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 153
TABLE 103 GERMANY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 154
TABLE 104 GERMANY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 105 GERMANY: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 106 GERMANY: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 107 GERMANY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 155
TABLE 108 GERMANY: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 156
TABLE 109 GERMANY: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 156
TABLE 110 GERMANY: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 157
TABLE 111 GERMANY: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 157
10.3.2 UK 157
10.3.2.1 Acceptance of flow cytometry products for clinical applications to propel market growth 157
TABLE 112 UK: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 158
TABLE 113 UK: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 159
TABLE 114 UK: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 115 UK: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 116 UK: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 117 UK: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 160
TABLE 118 UK: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 161
TABLE 119 UK: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 161
TABLE 120 UK: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 162
TABLE 121 UK: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 162
10.3.3 FRANCE 162
10.3.3.1 Strong government funding for proteomics & genomics research to drive market growth 162
TABLE 122 FRANCE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 163
TABLE 123 FRANCE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 164
TABLE 124 FRANCE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 164
TABLE 125 FRANCE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 164
TABLE 126 FRANCE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 127 FRANCE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 128 FRANCE: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 166
TABLE 129 FRANCE: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 166
TABLE 130 FRANCE: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 167
TABLE 131 FRANCE: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.3.4 ITALY 167
10.3.4.1 Rising geriatric population and increasing activities in life science to drive market growth 167
TABLE 132 ITALY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 168
TABLE 133 ITALY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 169
TABLE 134 ITALY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 135 ITALY: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 136 ITALY: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 170
TABLE 137 ITALY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 170
TABLE 138 ITALY: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 171
TABLE 139 ITALY: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 171
TABLE 140 ITALY: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 172
TABLE 141 ITALY: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 172
10.3.5 SPAIN 173
10.3.5.1 Growing focus on cancer diagnosis to drive demand 173
TABLE 142 SPAIN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 173
TABLE 143 SPAIN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 174
TABLE 144 SPAIN: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 145 SPAIN: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 146 SPAIN: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 147 SPAIN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 148 SPAIN: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 176
TABLE 149 SPAIN: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 176
TABLE 150 SPAIN: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 177
TABLE 151 SPAIN: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 177
10.3.6 REST OF EUROPE (ROE) 177
TABLE 152 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 178
TABLE 153 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 178
TABLE 154 REST OF EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 179
TABLE 155 REST OF EUROPE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 179
TABLE 156 REST OF EUROPE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 179
TABLE 157 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 180
TABLE 158 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS, 2020–2027 (USD MILLION) 180
TABLE 159 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2020–2027 (USD MILLION) 181
TABLE 160 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS, 2020–2027 (USD MILLION) 181
TABLE 161 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2020–2027 (USD MILLION) 182

ページTOPに戻る

Table of Contents

Summary

The global flow cytometry market is projected to reach USD 6.9 billion by 2027 from USD 4.7 billion in 2022, at a CAGR of 8.1% during the forecast period. Rising prevalence of HIV/AIDS, cancer & autoimmune diseases across the globe is increasing adoption of flow cytometry for diagnosis hence projecting the market growth. Additionally, launch of technologically advent product is furthermore likely to propel the market growth during the forecast period of 2022-2027.

“Instruments segment held a substantial share in the global flow cytometry market in 2021.”

Based on product & services, the market is segmented into reagents & consumables, instruments, services, software and accessories. The reagents & consumables segment held a dominant share in the market in 2021 and anticipated to continue dominance during the forecast period. Launch of new reagents & consumables in the market which are making research to grow at faster pace is likely to drive segmental growth. In November 2021, Bio-Rad Laboratories, Inc. (US), launched StarBright UltraViolet 400 Dye, fluorescent nanoparticles designed for use with a UV laser in flow cytometry applications.

“Research applications segment dominated the market in 2021.”

Based on end user, the flow cytometry market is segmented into research applications, clinical applications, and industrial applications. Strong focus of key market players in the clinical applications of flow cytometry is likely to project the segmental growth. For isnatnce, in October 2021, BD (Becton, Dickinson and Company)(US), in collaboration with Christian Medical College Vellore (India) launched its second Center of Excellence (CoE) in flow cytometry for clinical research in India.

“North America held dominant share in 2021.”
Geographically, the flow cytometry market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2021, North America accounted for the major share in the flow cytometry market. North America held dominant share owing to presence of key market players coupled with increased adoption of flow cytometry in research application in the region. Asia Pacific is expected to grow at faster pace due to increased research funding and adoption of flow cytometry in clinical applications.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type – Supply Side: 70.0%, Demand Side: 30.0%
• By Designation – Managers: 45.0%, CXOs & Directors:30.0%, Excecutives:25.0%
• By Region - North America: 20%, Europe: 10%, Asia Pacific: 55%, Latin America: 10%, and the Middle East and Africa: 5%
List of Companies Profiled in the Report
o Becton, Dickinson and Company (US)
o Danaher Corporation (US)
o Thermo Fisher Scientific, Inc. (US)
o Luminex Corporation (US)
o Agilent Technologies, Inc. (US)
o Sony Group Corporation (Japan)
o Bio-Rad Laboratories, Inc. (US)
o Miltenyi Biotec GmbH (Germany)
o Enzo Biochem, Inc. (US)
o Sysmex Corporation (Japan)
o bioMérieux S.A. (France)
o Cytonome/ST, LLC (US)
o Sartorius AG (Germany)
o Cytek Biosciences, Inc. (US)
o Union Biometrica, Inc. (US)
o Apogee Flow Systems Ltd. (UK)
o Stratedigm, Inc. (US)
o NanoCellect Biomedical, Inc. (US)
o On-chip Biotechnologies, Co., Ltd. (Japan)
o BennuBio Inc. (US)
o ORFLO Technologies (US)
o Bay Biosciences Co., Ltd. (Japan)
o BioLegend, Inc. (US)
o CytoBuoy B.V (Netherlands).
Research Coverage:
This report provides a detailed picture of the global flow cytometry market. It aims at estimating the size and future growth potential of the market across different segments, such as technology, product & services, application, end user and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total flow cytometry market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on cell analysis offered by the top 25 players in the flow cytometry market. The report analyses the flow cytometry market by technology, product & services, application, end user and region.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various flow cytometry products across key geographic regions.

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the flow cytometry market.

• Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the flow cytometry market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（非耐久財）の最新刊レポート

MarketsandMarkets社の非耐久財分野での最新刊レポート

本レポートと同じKEY WORD（end user）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（非耐久財）の最新刊レポート

MarketsandMarkets社の非耐久財分野での最新刊レポート

本レポートと同じKEY WORD（end user）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?